RFFC:ARCA-RiverFront Dynamic US Flex-Cap

ETF | Others | NYSE Arca

Last Closing

USD 33.196

Change

-0.02 (-0.07)%

Market Cap

USD 6.73M

Volume

6.10K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to provide capital appreciation. The fund invests at least 65% of its net assets in a portfolio of equity securities of publicly traded U.S. companies. Equity securities include common stocks and common or preferred shares of real estate investment trusts. The fund may invest in small-, mid- and large-capitalization companies. It is non-diversified.

Inception Date: 06/06/2016

Primary Benchmark: S&P 1500 TR

Primary Index: S&P 500 TR USD

Gross Expense Ratio: NA%

Management Expense Ratio: 0.52 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
SCPS Scopus Biopharma Inc 2.64 %
EMMA Emmaus Life Sciences Inc 2.14 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-10-16 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
SOJE SOJE 0.00 %

+0.04 (+0.21%)

USD 65.72B
JEPI JPMorgan Equity Premium Income.. 0.00 %

-0.11 (-0.20%)

USD 32.78B
LCR Leuthold Core ETF 0.00 %

-0.09 (-0.27%)

USD 32.52B
DTB DTB 0.00 %

-0.12 (-0.63%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2.. 0.00 %

-0.03 (-0.10%)

USD 26.11B
JPST JPMorgan Ultra-Short Income ET.. 0.00 %

N/A

USD 22.47B
SGOV iShares® 0-3 Month Treasury B.. 0.00 %

+0.03 (+0.03%)

USD 18.58B
TSPA T. Rowe Price US Equity Resear.. 0.00 %

-0.07 (-0.22%)

USD 16.23B
DFUV Dimensional US Marketwide Valu.. 0.00 %

+0.04 (+0.10%)

USD 10.15B
AVUV Avantis® U.S. Small Cap Value.. 0.00 %

+0.02 (+0.02%)

USD 10.05B

ETFs Containing RFFC

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.39% 63% D 58% F
Dividend Return 0.93% 28% F 18% F
Total Return 15.33% 61% D- 54% F
Trailing 12 Months  
Capital Gain -3.92% 26% F 36% F
Dividend Return 1.20% 30% F 21% F
Total Return -2.72% 25% F 34% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain 6.04% 77% C+ 70% C-
Dividend Return 6.86% 72% C 62% D
Total Return 0.82% 27% F 19% F
Risk Return Profile  
Volatility (Standard Deviation) 10.44% 50% F 69% C-
Risk Adjusted Return 65.64% 69% C- 72% C
Market Capitalization 6.73M 55% F 27% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.